Mrs Rose Mary Porter-fetterman, | |
20346 Ennis Rd, Georgetown, DE 19947-4108 | |
(302) 856-1926 | |
(302) 856-1950 |
Full Name | Mrs Rose Mary Porter-fetterman |
---|---|
Gender | Female |
Speciality | Psychologist - School |
Location | 20346 Ennis Rd, Georgetown, Delaware |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255649935 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TS0200X | Psychologist - School | 51843 (Delaware) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Rose Mary Porter-fetterman, 20346 Ennis Rd, Georgetown, DE 19947-4108 Ph: (302) 856-1926 | Mrs Rose Mary Porter-fetterman, 20346 Ennis Rd, Georgetown, DE 19947-4108 Ph: (302) 856-1926 |
News Archive
The immune system is normally known for protecting the body from illness. But a subset of immune cells appear to be doing more harm than good.
The largest delegation of UK healthcare companies took part in this year's China Medical Equipment Fair (CMEF); waving the British flag for innovation in China.
Though there is "significant risk" of a resurgence of polio in 2013, a new report from the Independent Monitoring Board (IMB) of the Global Polio Eradication Initiative (GPEI) is optimistic about the eradication of the disease, noting that 99.9 percent of polio has been stopped worldwide, with 175 cases reported so far in 2012 compared with 350,000 reported in 1988, BBC News reports.
ACT Biotech Inc., a privately held biotechnology company based in San Francisco, California, today announced positive interim data from a Phase 2 trial of the Company's lead oral kinase inhibitor, Telatinib, for the first-line treatment of patients with advanced gastric cancer. This proof-of-concept, multi-center, open label trial was designed to test the efficacy and safety of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.
SpinalMotion, developer of the investigational Kineflex® lumbar and Kineflex/C® cervical disc implants for treating patients with degenerative disc disease (DDD), today reported that it has submitted the Pre-Market Approval (PMA) to FDA for the Kineflex lumbar artificial disc
› Verified 4 days ago
Michael Lecompte, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 17099 County Seat Hwy, Georgetown, DE 19947 Phone: 302-856-2542 | |
Glenda Bowden, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 24506 Cedar Ln, Georgetown, DE 19947 Phone: 302-573-1247 | |
Katie Rae Owens, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 20346 Ennis Rd, Georgetown, DE 19947 Phone: 302-856-1926 Fax: 302-856-1950 | |
Doris Donaway, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 17 Merganser Rd Lot 95, Georgetown, DE 19947 Phone: 302-573-1247 | |
Dr. Ryna Jill Linden, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 12 E Pine St, Georgetown, DE 19947 Phone: 302-854-6688 Fax: 302-855-9492 | |
Olise Johnson, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 25315 Bethesda Rd, Georgetown, DE 19947 Phone: 302-573-1247 |